Biosimilar Newsletter Archive

91. 04.11.24 -- Proactive BioPharma Supplier Management 4/11/2024
    04/11/24 Biosimilar Development Newsletter
92. 04.04.24 -- A New Model Approach To Drug Shortage Prevention 4/4/2024
    04/04/24 Biosimilar Development Newsletter
93. 03.28.24 -- Meet "MAM," The New Quality Control Strategy On the Block 3/28/2024
    03/28/24 Biosimilar Development Newsletter
94. 03.22.24 -- Packaging And Containment Insights To Get To Market Faster 3/22/2024

    03/22/24 Biosimilar Development Newsletter

95. 03.21.24 -- Biosimilars Forum Urges Congress To Reform PBMs 3/21/2024
    03/21/24 Biosimilar Development Newsletter
96. 03.14.24 -- Understanding & Navigating Diverse Regulatory Environments 3/14/2024
    03/14/24 Biosimilar Development Newsletter
97. 03.07.24 -- Cardinal Health Report Examines Milestone Year In Biosimilars 3/7/2024
    03/07/24 Biosimilar Development Newsletter
98. 03.03.24 -- Samsung Bioepis Initiates Ph. 1 For Keytruda Biosimilar 3/3/2024
    03/03/24 Biosimilar Development Newsletter
99. 02.29.24 -- Samsung Bioepis Initiates Ph. 1 For Keytruda Biosimilar 2/29/2024
    02/29/24 Biosimilar Development Newsletter
100. 02.22.24 -- Analyzing & Kickstarting Organizational Quality Maturity 2/22/2024
     02/22/24 Biosimilar Development Newsletter